JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Abivax shares surge after report flags continued Eli Lilly takeover interest
-
-
-
-
-
-
-
Eli Lilly Q2 earnings preview: analysts eye obesity drug sales momentum
-
-
-
-
-
-
-
Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance
-
-
-
-
-
-
-
JPMorgan refreshed its U.S. Analyst Focus List and added these four names
-
-
-
-
-
-
-
Weight loss drug windfall attracts pharma companies
-
-
-
-
-
-
-
Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY), Zoetis (ZTS) top biopharma growth ideas for 2023 - JP Morgan
-
287,790 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

